Russell P. Beyer serves as Executive at SAB Biotherapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Russell P. Beyer has executed 6 insider transactions totaling $2.2K, demonstrating a bearish approach to their equity position. Their most recent transaction on Oct 26, 2021 involved selling 278 shares valued at $2.2K.
Russell P. Beyer currently holds 278 shares of SAB Biotherapeutics, Inc. (SABS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Russell P. Beyer has been a net seller of SABS stock. They have purchased $0 and sold $2.2K worth of shares.
Russell P. Beyer's most recent insider trade was on Oct 26, 2021, when they sold 278 shares at $7.90 per share.
Get notified when new Form 4 filings are submitted
| $7.78 |
| Discretionary |
| Oct 18, 2021 | SABS | $25.0K | Award | 2,475 | $10.10 | Discretionary |
| Sep 29, 2021 | SABS | $101 | Award | 10 | $10.08 | Discretionary |
| Sep 28, 2021 | SABS | $1.5K | Award | 149 | $10.08 | Discretionary |
| Sep 28, 2021 | SABS | $50 | Award | 5 | $10.07 | Discretionary |